Patterns of Mortality from Hereditary Ataxias in the United States, 1971 and 1973–1978

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Mortality rates for deaths ''due to'' and ''with'' hereditary ataxias are presented for the first time. Age-adjusted mortality rates were higher for whites than for nonwhites of either sex, and for men in both racial groups. Age-specific mortality rates for whites showed a peak for ''hereditary spinal ataxia'' in the 20–29 age group. For the other types of ataxias they were low until age 40 and increased thereafter. Heart diseases were a frequent cause of death in people dying ''with'' hereditary ataxias. The median survival (from birth) for hereditary spinal ataxia in whites was 35 years.

Related collections

Author and article information

Journal

Journal ID (publisher-id): NED

Journal ID (nlm-ta): Neuroepidemiology

Journal ID (doi): 10.1159/issn.0251-5350

Title: Neuroepidemiology

Publisher: S. Karger AG

ISSN (Print): 0251-5350

ISSN (Electronic): 1423-0208

Publication date Subscription-year: 1989

Publication date (Print): 1989

Publication date (Electronic): 15 June 1989

Volume: 8

Issue: 4

Pages: 193-199

Affiliations

Neuroepidemiology Branch, National Institute of Neurological and Communicative Disorders and Stroke, Intramural Research Program, NIH, Bethesda, Md., USA

Article

Publisher ID: 110182 Other ID: Neuroepidemiology 1989;8:193–199

DOI: 10.1159/000110182

PubMed ID: 2755550

SO-VID: 0a5c42ab-d052-4fc2-a184-a522c1091f6c

License:

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Call for Papers: Sex and Gender in Neurodegenerative Diseases

Submit here before September 30, 2024

Patterns of Mortality from Hereditary Ataxias in the United States, 1971 and 1973–1978

Read this article at

Abstract

Related collections

Karger: Neurology and Neuroscience

Author and article information

Journal

Affiliations

Article

History

Page count

Categories

Comments

Comment on this article

Similar content 260

Cited by 2